Johannes Zuber

52PUBLICATIONS
352CO-AUTHORS
Nanoscale characterisationPredictive and prognostic markersIndustrial molecular engineering of nucleic acids and proteinsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jun 25, 2026
Cellular assembly and functional resilience of the mammalian RNA exosome.

|Mar 06, 2026
Functional genomic screens uncover FERMT2 as a critical regulator of YAP/TAZ-driven tumorigenicity.

Arianna Chiesa, Vittoria Poli, Ottavio Croci

|Feb 04, 2026
A multivalent adaptor mechanism drives the nuclear import of proteasomes.

Hanna L Brunner, Robert W Kalis, Lorenz Grundmann

|Jan 28, 2026
In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation.

Lesly Calderón, Markus Schäfer, Marina Rončević

|Dec 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.

Cristina Queralt, Cristina Moreta-Moraleda, Marta Costa

|Nov 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

Pageof 9

Frequent Collaborators

8 joint publications

Tobias Neumann

8 joint publications

Julian Jude

6 joint publications

Robert W Kalis

6 joint publications

Florian Grebien